Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
Annals of Laboratory Medicine
; : 180-193, 2017.
Article
de En
| WPRIM
| ID: wpr-8638
Bibliothèque responsable:
WPRO
ABSTRACT
Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Arylamine N-acetyltransferase
/
Embolie pulmonaire
/
Tuberculose
/
Warfarine
/
Maladie des artères coronaires
/
Ticlopidine
/
Laboratoires hospitaliers
/
Antiagrégants plaquettaires
/
Cytochrome P-450 CYP2D6
/
Trouble dépressif
Type d'étude:
Guideline
langue:
En
Texte intégral:
Annals of Laboratory Medicine
Année:
2017
Type:
Article